Advertisement

Ads Placeholder
Loading...

SynBiotic SE

SBX.DEXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
1.90
-0.13(-6.17%)
German Market opens in 1h 14m

SynBiotic SE (SBX.DE) Stock Forecast & Price Predictions

Get the latest SynBiotic SE (SBX.DE) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price€2.41
Change↑ €0.51 (26.84%)

Quarterly Forecast

Predicted Price€1.26
Change↓ €-0.64 (-33.68%)

Yearly Forecast

Predicted Price€1.33
Change↓ €-0.57 (-29.99%)

3 Years Forecast

Predicted Price€0.00
Change↓ €-1.90 (-100.00%)

5 Years Forecast

Predicted Price€0.00
Change↓ €-1.90 (-100.00%)

7 Years Forecast

Predicted Price€0.00
Change↓ €-1.90 (-100.00%)

SynBiotic SE Stock Forecast Summary

SynBiotic SE (SBX.DE) stock is currently priced at $1.90. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $2.41.

In the long term, SBX.DE shows a bearish trend. The 2027 forecast points to $1.33 (-29.99% change), while the 2031 forecast suggests $0.00 (-100.00% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bullish

Long-Term Outlook

Bearish

This mix indicates that SynBiotic SE stock is expected to face downside risk over the coming years.

Investment Calculator

Estimate your potential returns on SBX.DE based on our AI price forecasts. Enter your investment amount and select a target date.

Based on your investment of 1,000.00 in SynBiotic SE and holding until April 3rd, 2027, you could make a potential 299.94 loss, reflecting a -30.0% ROI over the next 365 days.

$Shares Bought

526.3158

@ €1.90/share

~Forecast Price

€1.33

1-year AI forecast

$Est. Portfolio Value

€700.06

€299.94 loss

%ROI

-30.0%

return on investment

SynBiotic SE yearly Price Forecast Chart

Explore the yearly forecast chart for SBX.DE, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate SynBiotic SE over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for SBX.DEForecasting details for SBX.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

SynBiotic SE Stock Forecast 2026

The forecast for SynBiotic SE (SBX.DE) in 2026 suggests a price of $1.33, representing a -29.99% move from today’s price.

Average Target: $1.33

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Frequently Asked Questions